"What, sir, would you make a ship sail against the wind and currents by lighting a bonfire under her deck? I pray you, excuse me, I have not the time to listen to such nonsense."
Napoleon Bonaparte ; When told of the Robert Fulton steamboat
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8080683 | Electrochromic compound and electrochromic display device using the same An electrochromic compound represented by the following General Formula (1). A-(CX2)n—B General Formula (1) In the formula, A is a monovalent binding group, B is a redox chromophore, X is a halogen atom, and n is an i... | 12/20/2011 |
| 7358384 | Processes for the recovery of optically active diacyltartaric acids When a salt of an amine and an optically active diacyltartaric acid, or a diastereomer salt of an optically active amine and an optically active diacyltartaric acid, obtained by optically resolving a racemic amine using the optically active diacyltartaric acid, is s... | 04/15/2008 |
| 7358383 | Polyphenol proteasome inhibitors, synthesis, and methods of use The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in m... | 04/15/2008 |
| 7238831 | Mesogens Novel platform mesogens, intermediates, and polymerizable mesogens made therefrom. ... | 07/03/2007 |
| RE39593 | 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects 1-phenyl-3-dimethylaminopropane compounds corresponding to the formula I a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions. ... | 04/24/2007 |
| 7195719 | High polarization ferroelectric liquid crystal compositions The invention relates to chiral nonracemic liquid crystal compounds having achiral tails comprising a perfluoroalkyl terminal portion which are useful as components in liquid crystal to impart high polarization to the mixture. The materials of this invention can be ... | 03/27/2007 |
| 7083832 | Partially fluorinated liquid crystal material The invention provides LC compositions that exhibit V-shaped switching when aligned in an analog device configuration and exhibit bistability when aligned in a bookshelf-type device configuration. The invention more specifically provides LC compositions of formula 1... | 08/01/2006 |
| 7049308 | C-nitroso compounds and use thereof A C-nitroso compound having a molecular weight ranging from 225 to 1,000 (from 225 to 600 for oral administration) on a monomeric basis wherein a nitroso group is attached to a tertiary carbon, which is obtained by nitrosylation of a carbon acid having a pKa less th... | 05/23/2006 |
| 6905903 | Display unit and method of fabricating the same A display unit capable of inhibiting moisture and gas from penetrating into a liquid crystal layer and an alignment layer also after formation of a display electrode and suppressing decomposition of a material forming the display electrode is obtained. In this displ... | 06/14/2005 |
| 6753442 | Amorphous nitric esters and their pharmaceutical compositions Compounds of formula A—X1—ONO2 (I) in a partially or completely amorphous form and pharmaceutical compositions thereof. ... | 06/22/2004 |
| 6596193 | Electrooptical liquid crystal system To improve switching times, especially at low temperatures, one or more reactive liquid crystalline compounds is added to a liquid crystal mixture used in an electrooptical system. The electrooptical system comprises a PDLC film comprising a liquid crysta... | 07/22/2003 |
| 6565769 | Electrooptical liquid crystal system To improve switching times, especially at low temperatures, one or more reactive liquid crystalline compounds is added to a liquid crystal mixture used in an electrooptical system. The electrooptical system comprises a PDLC film comprising a liquid crystal mix... | 05/20/2003 |
| 6475574 | Direactive mesogenic compounds and intermediates The present invention generally relates to a direactive compound which is of the formula IV A R1 --(CH2)m O--MG--O--(CH2)n --R2 (IVA) wherein R1, R2, m, n, and MG are defined h... | 11/05/2002 |
| 6458757 | Method for preparing scenting compositions and scented products, and resulting products The present invention relates to a process for the production of perfuming compositions, to perfumed products, and to products obtained therefrom. More specifically, the present invention concerns a process for the production of perfuming compositions, pe... | 10/01/2002 |
| 6383499 | Topical medicament for the treatment of psoriasis A topical medicament for the treatment of psoriasis comprises metallic iodine, virgin wax, a variety of oils of animal and plant origin, camphor, chlorophyll and benzoic acid in a pharmaceutically acceptable emollient excipient base.... | 05/07/2002 |
| 6369262 | Diacrylate monomers and polymers formed therefrom Rigid-rod monomers and polymers are provided for use in applications such as rapid prototyping, composites and adhesives. The monomers can be photocured through the end groups and then thermally post cured through the acetylene groups. The result is a hig... | 04/09/2002 |
| 6369188 | Polyfunctional urethane- or urea-containing oligomers and polymers prepared therefrom Polyfunctional polymerizable urethane- or urea-containing oligomers allow the design, adjustment, and regulation of chemical and physical properties of the described oligomers. The invention discloses the formulas and compositions of these oligomers, meth... | 04/09/2002 |
| 6344558 | 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect 1-phenyl-3-dimethylaminopropane compounds corresponding to the formula I ##STR1## a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions.... | 02/05/2002 |
| 6262293 | ω-Cycloalkly-prostaglandin e2 derivatives ω-Cycloalkyl-prostaglandin E2 derivatives of formula (I) ##STR1## (wherein all symbols are as defined in the description); and non-toxic salts thereof, prodrugs thereof and cyclodextrin clathrates thereof. Compounds of formula (I) strongly bind on ... | 07/17/2001 |
| 6248737 | 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects 1-phenyl-3 -dimethylaminopropane compounds corresponding to the formula I ##STR1## a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions.... | 06/19/2001 |
| 6110955 | Metabolically stabilized oxyalkylene esters and uses thereof This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating cutaneous ulcers, treating gastrointestinal disorders, treating b... | 08/29/2000 |
| 6054457 | Benzamide derivatives and their use as vasopressin antagonists This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc, and represented by general formula (I): ##STR1## wherein R1 is aryl optionally substituted with lower alkoxy, etc., R2 is lower... | 04/25/2000 |
| 6020522 | Process for producing aromatic hydroxycarboxylic acid derivatives A methyl group-containing aromatic compound having a phenolic hydroxyl group protected by a protecting group, is oxidized with oxygen to provide an aromatic hydroxycarboxylic acid derivative. The protecting group includes, for example, an acyl group.... | 02/01/2000 |
| 6002042 | Liquid crystal compound A liquid crystal compound represented by the following general formula (1): ##STR1## wherein R is a linear alkyl group having 6 to 12 carbon atoms, X and Y are both a hydrogen atom, or one of them is a hydrogen atom and the other is a fluorine atom, ... | 12/14/1999 |
| 5939586 | Process for the production of intermediate for liquid crystal compound A process for the production of an intermediate for a liquid crystal compound, which comprises reacting an alkyloxybiphenylcarboxylic acid with purified thionyl chloride substantially free of sulfuryl chloride, the thionyl chloride being obtained by addin... | 08/17/1999 |
| 5831102 | Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes Enzymatically cleavable chemiluminescent 1,2-dioxetane compounds capable of producing light energy when decomposed, substantially stable at room temperature before a bond by which an enzymatically cleavable labile substituent thereof is intentionally clea... | 11/03/1998 |
| 5723066 | Electrooptical liquid crystal system An electrooptical system is disclosed in which a PDLC film is positioned between 2 electrode layers. The PDLC film contains a liquid crystal mixture forming microdroplets in an optically isotropic, transparent polymer matrix. The liquid crystal mixture co... | 03/03/1998 |
| 5650534 | Optically active smectic photo-cross-linkable liquid crystals The present invention is concerned with optically active, ferroelectric, smectic, photo-cross linkable compounds of the formula ##STR1## wherein A1 and A2 may both signify residues of the formula ##STR2## and be the same or... | 07/22/1997 |
| 5614486 | Cyclic diesters and their use as perfuming ingredients The compounds of formula ##STR1## wherein the Z group can be located in positions ortho-, meta- or para-relative to the carboxylic group, symbol R1 stands for a saturated or unsaturated, linear or branched C1 to C4 al... | 03/25/1997 |
| 5599359 | Polyalkylphenyl and polyalkyloxycarbonylphenyl hydroxybenzoates and fuel compositions containing the same A compound of the formula: ##STR1## wherein X is hydrogen or hydroxy, and Y is --R or --C(O)O--R, wherein R is a polyalkyl group having an average molecular weight of about from 450 to 5000; or a fuel soluble salt thereof. The compounds of formula I ... | 02/04/1997 |
| 5565606 | Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method The invention relates to compounds of the formula I ##STR1## in which A denotes hydrogen or an amino protective group, B denotes one or more amino acids, X denotes alkylene or aralkylene, Y1, Y2, Y3 and Y4 ... | 10/15/1996 |
| 5476860 | Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics Diaromatic compounds, characterized in that they correspond to the following general formula: ##STR1## in which: R1 is --CH3, --CH2 OH, --COR8 or --CH2 OCOR9, R8 is H, OH, -... | 12/19/1995 |
| 5468897 | Bi-aromatic esters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions Bi-aromatic esters have the formula ##STR1## wherein R1 represents H, OH, --CH3, --CH2 OH, --CH(OH)CH3, --COOR9, ##STR2## or SO2 R10 ; R9 represents H, C | 11/21/1995 |
| 5451339 | Liquid crystal monomeric compound and liquid crystal polymer compound modified therewith The present invention is to provide a liquid crystal monomeric compound where a liquid crystal phase readily appears, which is excellent in alignment control, film-formability, durability, heat-stability and compatibility, and is able to be applied to ele... | 09/19/1995 |
| 5447659 | Optically active benzene derivatives, process for producing the same and liquid-crystalline substances containing said derivatives as active ingredient and optical switching elements Disclosed are novel active benzene derivatives represented by the general formula (I): ##STR1## (wherein X represents --CCO--, --OCO--, --CH2 C-- or --OCH2 --; A represents a hydrogen atom, a halogen atom or an alkyl or alkoxyl ... | 09/05/1995 |
| 5380915 | Liquid-crystalline copolymer, process for the preparation of the same, diene compound used for the preparation of the same and process for the preparation of the diene compound A liquid-crystalline copolymer comprising the repeating units represented by the following general formulas ##STR1## wherein each of r and p is an integer of 2 to 5, q is an integer of 0 to 3, m is an integer of 1 to 20, and R1 is ##S... | 01/10/1995 |
| 5344959 | Tetrahydronaphthyl and cyclopropyl substituted 1,3-butadienes having retinoid-like activity Compounds of the formula ##STR1## wherein m is 1-4; R1 -R4 independently are hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, or I; R5 is hydrogen, lower alkyl of 1 to 6 carbons, Cl, Br, I, lower alkoxy or lower thioa... | 09/06/1994 |
| 5338484 | Optically active benzene derivatives, process for producing the same and liquid-crystalline substances containing said derivatives as active ingredient and optical switching elements Disclosed are novel active benzene derivatives represented by the general formula (I): ##STR1## (wherein X represents --COO--, --OCO--, --CH2 O-- or --OCH2 --; A represents a hydrogen atom, a halogen atom or an alkyl or alkoxyl ... | 08/16/1994 |
| 5332856 | Bi-aromatic esters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions Bi-aromatic esters have the formula ##STR1## wherein R1 represents H, OH, --CH3, --CH2 OH, --CH(OH)CH3, --COOR9, ##STR2## or SO2 R10 ; R9 represents H, C | 07/26/1994 |
| 5332675 | Optically active aromatic carboxylic acid derivatives and process for producing the same Disclosed are optically active aromatic carboxylic acid derivatives represented by the formula (I): ##STR1## (wherein R2 represents an alkoxyalkyl group having 1 to 20 carbon atoms or an alkyl group having 1 to 20 carbon atoms, which alkyl... | 07/26/1994 |